Social Media Ideas for Arkg

ARKK: Adding Exposure To Private Companies

ARK Brings $1.3B Venture Fund Onchain Through Securitize

ARK Invest is tokenizing its ARK Venture Fund through Securitize. The fund has roughly $1.3 billion in assets and invests across private and public technology companies including O...

ARK asks SEC to approve tokenized share class for $562M venture fund

ARK Investment Management has asked the U.S. Securities and Exchange Commission to approve a tokenized share class for its $562 million venture fund, allowing ownership records to...

ARK Space & Defense or SPDR Aerospace & Defense: Which ETF Can Power Your Portfolio?

ARKX delivers higher returns but charges double the fees and carries greater volatility. XAR offers lower costs and broader diversification across 50 holdings.

Anthropic IPO 2026: What Investors Need To Know And How To Get Exposure Today With AI ETF AGIX

Argenx

Argenx Anonymous (not verified) Mon, 10/19/2026 - 10:14 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

ARK Invest tokenizes venture fund with OpenAI exposure

ARK Invest has tokenized its ARK Venture Fund through Securitize on Ethereum, giving eligible investors a blockchain-based way to hold an interest in a portfolio that includes Open...

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13...

Arrowhead Pharmaceuticals: The Fast-Follower Math Behind A $215 Million Voucher

AMG River Road Dividend All Cap Value Fund Q2 2026 Commentary

GStocks PH makes investing in Arthaland follow-on offering more accessible

Filipinos can look forward to easily participating in Arthaland Corporation’s (ALCO) upcoming Series G and H preferred share offering, giving investors an opportunity to invest in...

Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency

ARK Investment Management increases Meta holdings, reduces Alphabet stake

ARK's strategic shift highlights a bold bet on Meta's AI potential, challenging prevailing market views and signaling confidence in innovation. The post ARK Investment Management i...

Cathie Wood Trimmed Ark's Alphabet Stake Even as Google Search Revenue Grew, While Ark Piled Into Rocket Lab Even After...

Cathie Wood is buying more Rocket Lab despite its Neutron launch delay while trimming stake in Alphabet.

Ark Invest sells Palantir and AMD, boosts stake in Archer Aviation

ARK Invest's shift highlights a strategic pivot towards emerging tech, potentially influencing market dynamics and investor sentiment in eVTOL. The post Ark Invest sells Palantir a...

Acrux Limited (ARUXF) Shareholder/Analyst Call Transcript

Argo Graphene amends $1 million financing, advances STREAM graphene commercialization

Argo Graphene Solutions Corp. (CSE: ARGO), developer of the STREAMâ„¢ graphene production platform, has amended the terms of the non-brokered private placement it announced earlier...

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between Marc...

Paxos’ $3B USDG stablecoin launches on Arbitrum

Paxos’ USDG stablecoin is now live on Arbitrum as the network proposes 100 million ARB in incentives to support adoption and liquidity.Paxos-issued stablecoin Global Dollar (USDG)...

AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pu...

Arjo AB (publ) (ARRJF) Analyst/Investor Day - Slideshow

ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March...

Cathie Wood’s ARK adds to Scribe Therapeutics stock position

This Little-Known Altcoin Powering Robinhood's New Blockchain Just Soared By 45%. Is ARB a Buy, Sell, or Hold?

Arbitrum is in the spotlight for the first time, and it's performing well.